In 2016, Michael DeMane earned $533.69K in total compensation at Neuro Corp, primarily from $520.83K salary. Most recently acquired 7,056 shares in Dec 2024. Has donated $467.20K in stock to charitable causes. Led Neuro Corp as CEO for 1 years.
Compensation History
Annual executive compensation data for Michael DeMane, including salary, bonuses, and stock awards.
Year
2016
Total Compensation
$533.69K
Salary
$520.83K
Bonus
$0.00
Other
$12.86K
Salary
$520.83KBoard Justification
The compensation philosophy is designed to attract and retain executive talent while aligning compensation with company performance and market benchmarks.
Bonus
$0.00Board Justification
No bonus was awarded for the year 2016 as per the compensation structure.
Other Compensation
$12.86KBoard Justification
Other compensation includes reimbursement for commuting costs and other benefits.
Restricted Stock
Board Justification
No stock was vested in 2016 as per the compensation structure.
Performance Metrics
Performance metrics for the year included achieving revenue targets and operational goals.
Michael DeMane
Ex-CEO of Neuro Corp
Education
M.B.A. from Harvard Business School
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
January 1, 1971 - 54 years ago
CEO of Neuro Corp for
1 year 5 months (Jan 2015 - Jun 2016)
Previous Experience
Prior to joining Nevro, served as the Chief Executive Officer of several medical device companies.
Other Neuro Corp CEOs
Holdings
Track Michael DeMane's stock holdings and portfolio value over time.
Total Stock Sold
$65.64M
$65.64M
683,959 NVRO shares
What if they kept their stock?
If Michael DeMane didn't sell their stock, today they would have:
Extra NVRO683,959 shares worth $3.99M.
This is -93.91% and $61.64M less than what they got when they sold the stock.
Charitable Transactions
80,000 shares
NVRO
Recent Charitable Transactions
80,000 shares
NVRO
Jun 7, 2023
Charity
Insider Trading
Michael DeMane's recent stock transactions, purchases, and sales filed with the SEC.
7,056 shares
NVRO
Dec 31, 2024
Received
4,695 shares
NVRO
Sep 30, 2024
Received
3,117 shares
NVRO
Jun 30, 2024
Received
19,169 shares
NVRO
May 23, 2024
Received
1,817 shares
NVRO
Mar 31, 2024
Received
1,219 shares
NVRO
Dec 31, 2023
Received
1,365 shares
NVRO
Sep 30, 2023
Received
1,032 shares
NVRO
Jun 30, 2023
Received
80,000 shares
NVRO
Jun 7, 2023
Charity
6,754 shares
NVRO
May 25, 2023
Received
Rivals
Compare Michael DeMane with competitor CEOs and industry peers.